Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 20;10(5):e26562.
doi: 10.1016/j.heliyon.2024.e26562. eCollection 2024 Mar 15.

Protective effects of hepatic diseases by bioactive phytochemicals in Fusarium oxysporum - A review

Affiliations
Review

Protective effects of hepatic diseases by bioactive phytochemicals in Fusarium oxysporum - A review

Nashwa M Shalapy et al. Heliyon. .

Abstract

Lately, liver diseases were categorized as one of the most prevalent health problems globally as it causes a severe threat to mankind all over the world due to the wide range of occurrence. There are multiple factors causing hepatic disorders, such as alcohol, virus, poisons, adverse effects of drugs, poor diet, inherited conditions and obesity. Liver diseases have various types including alcoholic liver disease, non-alcoholic fatty liver disease, autoimmune hepatitis, liver cancer, hepatocellular carcinoma, liver fibrosis and hepatic inflammation. Therefore, it is imperative to find effective and efficacious agents in managing liver diseases. Fusarium oxysporum, an endophytic fungus and containing many bioactive compounds, could be served as a forked medication for enormous number and types of maladies. It was characterized by producing biochemical compounds which had rare pharmacological properties as it may be found in a limit number of other medicinal plants. The majority of the past researches related to Fusarium oxysporum recited the fungal negative field either on the pathogenic effects of the fungus on economical crops or on the fungal chemical components to know how to resist it. The present review will highlight on the bright side of Fusarium oxysporum and introduce the functional activities of its chemical compounds for treating its target diseases. The key point of illustrated studies in this article is displaying wide range of detected bioactive compounds isolated from Fusarium oxysporum and in other illustrated studies it was elucidated the therapeutical and pharmacological potency of these biologically active compounds (isolated from medicinal plants sources) against different types of liver diseases including non-alcoholic fatty liver disease, alcoholic liver disease, cirrhosis and others. It was demonstrated that F. oxysporum contains unique types of isoflavones, flavonoids, phenols and another active chemical compounds, and these compounds showed recently a fabulous clinical contribution in the therapy of liver injury diseases, which opens new and unprecedented way for evaluating the maintaining efficacy of Fusarium oxysporum bioactive compounds in dealing with hepatic complications and its remedy impacting on liver diseases and injured hepatocytes through recommending implement a practical study.

Keywords: Alcoholic liver disease; Cirrhosis; Efficacy; Fungal bioactive compounds; Fusarium oxysporum; Hepatic disorders; Liver inflammatory disease; Non-alcoholic fatty liver disease; Oxidative stress; Therapeutic effects.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Wenyi Kang reports financial support was provided by Research on Precision Nutrition and Health Food, 10.13039/501100006407Department of Science and Technology of Henan Province (CXJD2021006). Wenyi Kang reports a relationship with Research on Precision Nutrition and Health Food, 10.13039/501100006407Department of Science and Technology of Henan Province (CXJD2021006). that includes: funding grants. There is no room for wrong interpretation by the reader as conflict of interest.

Similar articles

References

    1. Seitz H.K., Neuman M.G. The history of alcoholic liver disease: from an unrecognized disease to one of the most frequent diseases in hepatology. J. Clin. Med. 2021;10(4):858. - PMC - PubMed
    1. World Health Organization (Who) 2014. Global Status Report on Alcohol and Health.
    1. Sivakrishnan S. Liver diseases-an overview. World J. Pharm. Pharmaceut. Sci. 2019;8(1):1385–1395.
    1. Zhang C., Liu S., Yang M. Antioxidant and anti-inflammatory agents in chronic liver diseases: molecular mechanisms and therapy. World J. Hepatol. 2023;15(2):180–200. - PMC - PubMed
    1. Embade N., Millet O. Molecular determinants of chronic liver disease as studied by NMR-Metabolomics. Curr. Top. Med. Chem. 2017;17:2752–2766. - PubMed

LinkOut - more resources